Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diabetes Prevention in the VITAL Trial
NCT01633177Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Nov 2011
- Primary completion
- May 2024
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of vitamin d, omega-3-acid triglycerides in type 2 diabetes mellitus (T2DM), sponsored by Brigham and Women's Hospital. Started Nov 2011; status: completed.
02
Drugs
vitamin domega-3-acid triglycerides
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01633177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01633177.